An experimental Alzheimer’s medication slowed declines in patients’ ability to think clearly and perform daily tasks by more than a third in a large clinical trial, drugmaker Eli Lilly said. CNN medical correspondent Meg Tirrell reports.
An experimental Alzheimer’s medication slowed declines in patients’ ability to think clearly and perform daily tasks by more than a third in a large clinical trial, drugmaker Eli Lilly said. CNN medical correspondent Meg Tirrell reports.
More News
Pro-Palestinian movement is ‘mushrooming’ on campuses across US | CNN
Fmr. defense secy reacts to Supreme Court Trump immunity case | CNN
Should Clarence Thomas recuse on Jan.6 cases? | CNN Politics